Welwyn Garden City, United Kingdom

Frank R Atherton

This inventor holds 7 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1977-1981.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank R Atherton. Retrieved from https://idiyas.com/inventor/frank-r-atherton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 6

Forward Citations = 67(Granted Patents)


Location History:

  • Welwyn Garden City, EN (1977)
  • Welwyn Garden City, GB (1978 - 1981)

Company Filing History:


Years Active: 1977-1981

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Frank R. Atherton: Innovator in Antibacterial Compounds

Introduction

Frank R. Atherton is a notable inventor based in Welwyn Garden City, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antibacterial agents. With a total of 7 patents to his name, Atherton's work has had a considerable impact on the pharmaceutical industry.

Latest Patents

Among his latest patents, Atherton has developed acyl derivatives that include peptide derivatives. These compounds are characterized by a general formula where R¹ can represent a hydrogen atom or various alkyl groups. The compounds exhibit activity as antibacterial agents against a range of gram-positive and gram-negative bacteria. Additionally, he has worked on halo-phosphonopeptides, which are also recognized for their antibacterial properties and their ability to enhance the effectiveness of antibiotics.

Career Highlights

Frank R. Atherton is currently associated with Hoffmann-La Roche Inc., a leading global healthcare company. His innovative work in the field of antibacterial agents has positioned him as a key figure in pharmaceutical research and development. Atherton's contributions are vital in the ongoing battle against bacterial infections.

Collaborations

Throughout his career, Atherton has collaborated with esteemed colleagues, including Michael J. Hall and Cedric H. Hassall. These partnerships have fostered a collaborative environment that enhances the research and development of new medicinal compounds.

Conclusion

Frank R. Atherton's innovative work in the field of antibacterial compounds has made a significant impact on medicine. His contributions continue to advance the development of effective treatments against bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…